MGRM monogramorthopedics.com: Company Value to Revenue

Official company branding of Monogram Orthopedics (MGRM)

Monogram Technologies' commitment to reducing operational waste and the environmental footprint of its equipment is reflected in its price action. The Enterprise Value-to-revenue ratio demonstrates market expectations, with the value stabilizing at . Growth is driven by innovations in AI visualization for 3D milling of implants and the development of high-precision robotic platforms, creating long-term capitalization potential.

monogramorthopedics.com (MGRM): Enterprise Value-to-Revenue Ratio from 07/04/2022 to 11/19/2026

MGRM (Monogram Orthopedics Inc.): analytical breakdowns and indicator data

- current quotes and average value forecast:
Initial company analysis:Monogram Technologies
Manufactured products of Monogram Technologies Inc

The stability of Monogram Technologies (MGRM) is driven by the scaling of AI-powered robotic systems integration into surgery. This factor directly impacts the EV/Sales ratio, which combines market capitalization and net debt. This metric measures the total enterprise value divided by sales volume, neutralizing the impact of the financing structure. This allows the investor to see the actual premium attributed to the product's technological sophistication. When analyzing the ratio of enterprise value to annual revenue, it should be benchmarked against profit growth rates.

Competitor analysis

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio STERIS plc|Company Value to Revenue Ratio WST (West Pharmaceutical Services)|Company Value to Revenue BAX (Baxter Corp)|Masimo - Company Value to Revenue Ratio|Stevanato Group S.p.A. - Company Value to Revenue|Total Company Value-to-Revenue Ratio Teleflex Inc (TFX)|MMSI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Envista Holdings Corp NVST|ICUI: EV/Sales Multiple|Company Value to Revenue Ratio XRAY|LMAT (LeMaitre Corp) - EV/Sales Multiple|ATRC (AtriCure Inc) - Enterprise Value-to-Revenue Coefficient|EV/Sales Multiple STAA|NAGE (ChromaDex Corp) - Business Value to Revenue|ZimVie Inc. - Company Value to Revenue|Total Company Value-to-Revenue Ratio angiodynamics.com (ANGO)|CERS - Enterprise Value-to-Revenue Ratio|TKNO - EV/Sales Multiple|Sharps Technology, Inc. (STSS) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Multiple InfuSystem Inc (INFU)|UTMD (Utah Medical Products Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple KORU Medical Systems KRMD|Enterprise Value-to-Revenue Ratio Nyxoah SA (NYXH)|Enterprise Value-to-Revenue Coefficient MBOT|EV/Sales Multiple PDEX (Pro-Dex Inc.)|Enterprise Value-to-Revenue Coefficient ZTEK (Zentek Limited)|elutia.com - EV/Sales Multiple|Business Value to Revenue MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Company Value to Revenue|Retractable Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio harvardbioscience.com|Femasys Corp (FEMY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple MHUA|Predictive Oncology Inc. - Company Value to Revenue Ratio|EV/Sales Multiple CJMB (Callan JMB Inc)|EV/Sales Multiple Atrion Corp ATRI|NeuroMetrix Corporation - EV/Sales Multiple